Overview
Drug interactions occur when the effect of one drug is altered by the concurrent presence of another drug, food, supplement, or disease state, producing changes in efficacy or toxicity. They are classified as pharmacokinetic, when one agent modifies the absorption, distribution, metabolism, or excretion of another, often through cytochrome P450 enzymes or transporters, or pharmacodynamic, when agents act additively, synergistically, or antagonistically at a shared target or pathway. Recognizing and managing interactions through medication review, decision support, and pharmacogenetic awareness is essential to safe prescribing, particularly with polypharmacy. Research relevant to this area includes quality assessment in anti-ulcer drug markets, medication-plan use as a quality indicator, the move from personalized medication toward customized nutrition, genetic polymorphisms in epilepsy pharmacotherapy, multi-drug antiretroviral regimens for HIV management, herb-drug combinations in diabetes, prescribing and dispensing practices under WHO core indicators, computer-aided drug design, and clinical decision-support systems for analgesic dosing. The journal publishes peer-reviewed work, grouped here under drug-resistant pathogen research and clinical pharmacology, addressing the mechanisms, identification, and clinical management of drug interactions, connecting pharmacokinetic and pharmacodynamic principles, prescribing practice, and pharmacogenetics to the optimization of medication safety and effectiveness.
Research published in this journal
12 peer-reviewed articles, ranked by relevance. Each links to its DOI.
Using a Medication Plan as a Quality Indicator: Feasibility and Satisfaction Results from an Observational Study
The Journey from Personalized Medication to Customized Nutrition
Genetic Polymorphisms in Patients with Epilepsy: A Mini Review.
Characterization of People Receiving 2-Drug Regimens (2DR) for HIV Management in Italy
Trigonella Foenum Graecum Extract Benefits on Hematological, Biochemical and Male Reproductive System as a Complementary Therapy with Glimepiride in Treating Streptozotocin Induced Diabetic Rats
Complementary and Alternative Treatments for Cancer Prevention and Cure (Part 1)
Rhabdomyolysis in a HIV-infected Patient Following the Addition of Raltegravir, A Case Report with Review of the Literature
Assessment of Prescribing and Dispensing Practices Based on WHO Core Prescribing Indicators in Hospital and Community Pharmacies in Khartoum State - Sudan
A Review on Drug Design by the Application of Computer
Integrating Analgesic Doses and Pain Trend Analysis: A Novel Clinical Support System
Artificial Intelligence in Healthcare: Enhancing Efficiency, Ensuring Equity, and Restoring Empathy
How this research is being cited
The 12 articles above have been cited 46 times in the scholarly literature. Citation data via OpenAlex and Crossref, updated Jun 2026.
-
2026 · Research Journal of Pharmacology and Pharmacodynamics
-
2025 · Regenerative Therapy
-
2024 · Regenerative Therapy
-
2024 · Clinical Epidemiology and Global Health
-
2024 · Journal of Pharmaceutical Policy and Practice
-
Liknew Workie Limenh · 2024 · Risk Management and Healthcare Policy
-
2024 · Clinical Epidemiology and Global Health
-
2024 · Journal of Pharmaceutical Policy and Practice
A sample of recent works citing this journal's research on Drug Interactions, linking to each citing work.